|
RPL35 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.54519763440453E-11 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.49139999928406E-09 |
| Normal-vs-Stage2 |
2.138100E-03 |
| Normal-vs-Stage3 |
1.835470E-04 |
| Normal-vs-Stage4 |
7.62370000000345E-05 |
| Stage1-vs-Stage2 |
4.371600E-01 |
| Stage1-vs-Stage3 |
3.944800E-01 |
| Stage1-vs-Stage4 |
3.637000E-04 |
| Stage2-vs-Stage3 |
9.777800E-01 |
| Stage2-vs-Stage4 |
2.977600E-02 |
| Stage3-vs-Stage4 |
1.636220E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.02770072638737E-11 |
| Normal-vs-AfricanAmerican |
2.42950000000075E-05 |
| Normal-vs-Asian |
4.396500E-02 |
| Caucasian-vs-AfricanAmerican |
8.806400E-01 |
| Caucasian-vs-Asian |
3.920400E-01 |
| AfricanAmerican-vs-Asian |
4.953600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.06039679446258E-11 |
| Normal-vs-Female |
1.80502000000082E-05 |
| Male-vs-Female |
8.408200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.64630000004862E-06 |
| Normal-vs-Extreme_Weight |
4.35680380661552E-11 |
| Normal-vs-Obese |
4.00109999998399E-06 |
| Normal-vs-Extreme_Obese |
1.013990E-01 |
| Normal_Weight-vs-Extreme_Weight |
6.893000E-01 |
| Normal_Weight-vs-Obese |
5.686400E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.600400E-01 |
| Extreme_Weight-vs-Obese |
7.554400E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.949600E-01 |
| Obese-vs-Extreme_Obese |
7.951000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.804500E-04 |
| Normal-vs-Age(41-60Yrs) |
7.8361994670928E-10 |
| Normal-vs-Age(61-80Yrs) |
9.67699997911353E-09 |
| Normal-vs-Age(81-100Yrs) |
1.895970E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.945200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.774200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.066600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.247600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.280400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.379600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.3276048583275E-11 |
| Normal-VS-Type2 PRCC |
1.805700E-04 |
| Normal-VS-KIRP CIMP |
9.764100E-04 |
| Normal-VS-Unclassified PRCC |
1.342740E-03 |
| Type1 PRCC-VS-Type2 PRCC |
2.660200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
3.037200E-04 |
| Type1 PRCC-VS-Unclassified PRCC |
2.590000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.502100E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
9.541800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.298960E-03 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.19809999998832E-06 |
| Normal-vs-N1 |
3.7273999999976E-05 |
| Normal-vs-N2 |
2.30289999958444E-07 |
| N0-vs-N1 |
7.854200E-02 |
| N0-vs-N2 |
8.001800E-02 |
| N1-vs-N2 |
5.106000E-01 |
|
|
